STE.NYSESteris PLC

Form 4: STERIS plc Senior VP Withholds Shares for Tax Obligations Following Restricted Stock Vesting

Sentiment:

Insider Transaction Report


John Adam Zangerle, Senior VP, General Counsel, and Secretary of STERIS plc, disposed of 425 ordinary shares valued at $242.1 each to cover tax liabilities related to the vesting of restricted stock.

Summary

  • John Adam Zangerle, Senior VP, General Counsel, and Secretary of STERIS plc, reported a transaction on June 4, 2025.
  • The transaction involved the disposition of 425 ordinary shares, which were withheld to satisfy tax obligations.
  • These 425 shares were part of 1,376 restricted shares that vested on June 4, 2025.
  • The vested shares were valued at the NYSE closing market price of $242.1 per share on June 4, 2025.
  • The original award date for these 1,376 ordinary shares was June 4, 2024.
  • Following this transaction, Mr. Zangerle beneficially owns 35,738 ordinary shares directly.
  • As of June 4, 2025, 8,713 of these ordinary shares remain restricted, with vesting schedules extending through June 5, 2028.

Sentiment

Score: 6

Explanation: The document reports a routine insider transaction related to executive compensation and tax obligations. It is neutral in its implications for the company's operational or financial performance, but the vesting of shares is generally a positive sign of executive retention and long-term incentives.

Positives

  • The vesting of restricted shares indicates the fulfillment of long-term incentive compensation for a key executive.
  • The transaction is a routine tax withholding, demonstrating compliance with employment and tax laws.

Negatives

  • The disposition of shares, while for tax purposes, slightly reduces the direct shareholding of a senior executive.

Future Outlook

The document outlines future vesting dates for 8,713 restricted ordinary shares held by Mr. Zangerle, extending through June 5, 2028, indicating continued long-term incentive alignment.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all industries for publicly traded companies. It reflects standard executive compensation practices involving restricted stock units and subsequent tax withholdings upon vesting.

Comparison to Industry Standards

  • The practice of withholding shares to cover tax obligations upon the vesting of restricted stock is a standard and widely accepted method of managing executive compensation in public companies, aligning with common industry practices for equity awards.
  • The disclosure format and content adhere to SEC regulations for insider trading reports (Form 4), consistent with global benchmarks for transparency in executive shareholdings.

Stakeholder Impact

  • Shareholders: Provides transparency into executive shareholdings and compensation practices. The routine nature of the transaction is unlikely to have a significant direct impact.
  • Employees: Reflects standard executive compensation practices, which may influence broader employee incentive programs.

Next Steps

  • Future vesting of 202 restricted ordinary shares on October 1, 2025.
  • Future vesting of 1,157 restricted ordinary shares on June 1, 2026.
  • Future vesting of 846 restricted ordinary shares on June 2, 2026.
  • Future vesting of 1,252 restricted ordinary shares on June 3, 2026.
  • Future vesting of 1,376 restricted ordinary shares on June 4, 2026.
  • Future vesting of 1,252 restricted ordinary shares on June 3, 2027.
  • Future vesting of 1,376 restricted ordinary shares on June 4, 2027.
  • Future vesting of 1,252 restricted ordinary shares on June 5, 2028.

Key Dates

DateDescription
2024-06-04Date 1,376 ordinary shares were awarded to Mr. Zangerle.
2025-06-04Date of transaction; 1,376 restricted shares vested, and 425 shares were withheld for taxes. Also, the valuation date for the vested shares.
2025-10-01Date 202 restricted ordinary shares lapse.
2026-06-01Date 1,157 restricted ordinary shares lapse.
2026-06-02Date 846 restricted ordinary shares lapse.
2026-06-03Date 1,252 restricted ordinary shares lapse.
2026-06-04Date 1,376 restricted ordinary shares lapse.
2027-06-03Date 1,252 restricted ordinary shares lapse.
2027-06-04Date 1,376 restricted ordinary shares lapse.
2028-06-05Date 1,252 restricted ordinary shares lapse.
2025-06-06Date the Form 4 was signed by the authorized representative.

Keywords

STERIS plc, STE, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Executive Compensation, Beneficial Ownership, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.